For the past couple of years, Jacob Gottlieb has maintained a low professional profile. However, he is back with a bang and has his own investment firm known as Altium Capital Management. For many years, Gottlieb has been one of the most accomplished experts in the healthcare industry. He has been a CEO and a top fund manager for various organizations. Gottlieb has created Altium Capital to fulfill his passionate dreams of running the best healthcare investment company. In creating the new company, his vision is aligned with the goals that he has of creating his next success story. Now that he is back in the industry, it is expected that significant changes will be witnessed in the future.
For the past two years, Gottlieb has been winding up the operations of the previous company he owned known as Visium Asset Management. This company was created to back in 2005 and became one of the most successful healthcare-focused investment funds. It attracted high-profile pension funds such as the School Employees Retirement System of Ohio and the New Jersey Estate Investment Council. By the time he was starting this firm, his reputation as a successful fund manager he was not in doubt. He incorporated 20 investment partners and pumped $300 million into the investment. By 2016, the investment had risen to over $8 billion. With experience from other organizations such as Merlin Biomed Group, Balyasny Asset Management, and Sanford C. Bernstein & Co, he was in a better position of succeeding as the owner of the largest portfolio in the healthcare Industry.
Under the leadership of Mr. Gottlieb, Visium attracted over 170 employees and opened multiple offices across the globe. They were offices in San Francisco, London, and New York. Between 2013 and 2016, his company doubled its assets. However, after this success, it hit by scandals emanating from some of his employees leading to its downfall. In the whole debacle, Gottlieb emerged unscathed.
After completing the closure of Visium, Jacob Gottlieb is back with Altium Capital. It is a healthcare-focused hedge fund which is looking to build a portfolio that will make a difference in the health care industry. With its first two investments, it is clear that they mean business. The first investment is in a company known as Oramed Pharmaceuticals, Inc., a healthcare company based in Jerusalem. This company has created a flagship product that will eliminate the use of traditional insulin by creating an oral drug. An oral drug is considered better than injecting insulin since the costs of treatment and infection rates are low. From this investment, it’s clear that Altium Capital is focused not only in local market but international. Altium Capital has also invested in another company known as Amarin. This one is involved in the manufacture of drugs that boost cardiovascular health.
Five months after introducing Altium Capital, Jacob Gottlieb released the performance records of the Altium Growth Fund. The fund has grown by 7.37 percent in five months. This is a remarkable achievement given that the company is in its first years of business. Going by this trend, it is expected that the firm will record even better results in the future. Mr. Gottlieb has created a management team composed of some of the brightest minds in the investment industry. This time he is ready to avoid the challenges that faced his previous company. With Altium Capital, he’s committed to creating in the most accomplished healthcare investment company in the world. With Altium Growth Fund, Gottlieb is even keen on investing even in the sub-sectors of the healthcare industry such as medical devices, services, biotechnology among others. With his comeback, the healthcare industry is likely to feel the heat of his actions.
